Gcom1 activators are a chemical class designed to modulate a specific type of G protein-coupled receptor (GPCR) known as Gcom1, which is a component of the intricate signaling pathways within cells. GPCRs are a large family of cell surface receptors that respond to various external stimuli and activate internal signal transduction pathways, which result in cellular responses. Gcom1 activators bind to the Gcom1 receptor, causing a conformational change that triggers the receptor's intrinsic activity. The precise mechanism by which these activators exert their influence involves the stabilization of the receptor in its active state, thereby enhancing its ability to interact with intracellular G proteins. These G proteins then go on to propagate the signal by activating or inhibiting downstream effectors, which can include enzymes, ion channels, and other regulatory proteins.
The biochemical processes initiated by Gcom1 activators are highly nuanced and are part of a complex cascade of events that regulate various aspects of cellular function. The Gcom1 receptor's response to activation can involve the modulation of cyclic adenosine monophosphate (cAMP) levels, intracellular calcium concentrations, and the activation of different kinases and phosphatases. The activators themselves are diverse in structure, ranging from small organic molecules to larger peptide-based compounds, each with a unique affinity and specificity to the Gcom1 receptor. The design and synthesis of these activators require a deep understanding of the receptor's structure and the molecular interactions necessary for activation. Scientists aim to fine-tune the activators' physicochemical properties to ensure proper engagement with the Gcom1 receptor, while minimizing off-target effects.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances Gcom1 activity by increasing intracellular cAMP levels, which activate protein kinase A (PKA) and can lead to the phosphorylation of proteins that are part of the Gcom1 signaling pathway. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, increasing intracellular calcium levels and potentially enhancing Gcom1 activity by activating calcium-dependent signaling pathways that Gcom1 is part of. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate target proteins within the signaling pathways that Gcom1 is involved in, thus indirectly enhancing Gcom1 activity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Sodium Nitroprusside releases nitric oxide (NO) which can stimulate soluble guanylyl cyclase, leading to increased cGMP levels and indirect enhancement of Gcom1 via cGMP-dependent pathways. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase type 5 (PDE5), leading to elevated cGMP levels and potentially enhancing Gcom1 activity through cGMP-dependent signaling mechanisms. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can activate PKA and leads to the enhancement of Gcom1 activity by influencing proteins that interact with or regulate Gcom1. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels, which can lead to PKA activation and enhancement of Gcom1 activity through cAMP-dependent pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, increasing levels of cAMP and cGMP, which can enhance Gcom1 activity through PKA and PKG activation, respectively. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine is a calcium channel blocker that can indirectly enhance Gcom1 activity by modulating calcium signaling pathways, potentially affecting Gcom1's functional role. | ||||||